Stereotaxic Injections

By Ben Hobson, BA and Adrien Stanley
View Published Protocol

Output Details

Description
Stereotaxic Injections for Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain
Identifier (DOI)
10.17504/protocols.io.5qpvoreezv4o/v1
Team
Team Sulzer
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

  • Ben Hobson, BA

    Key Personnel: Team Sulzer, 

    Columbia University

  • User avatar fallback logo

    Adrien Stanley

Related Research

Release Notes – ASAP CRN Cloud

Summary: Release notes for version 1.0.0 of CRN Cloud platform, released on June 25, 2024, detailing latest updates and enhancements.

View Dataset

Proteome Landscapes Decode Organelle Vulnerabilities in cortical and dopaminergic-like induced neurons Across Lysosomal Storage Disorders

Lysosomal Storage Disorders impact lysosomal function and can be linked to Parkinson's Disease risk. LSD mutant cells show varied endolysosomal proteomes, with specific disruptions in neuronal cells.

View Article

Leucine Rich Repeat Kinase 2: Pathways to Parkinson’s Disease

Research on LRRK2 in Parkinson's disease has advanced, revealing how mutations activate the kinase, phosphorylate Rab proteins, disrupt cell functions like Hedgehog signaling, and contribute to the disease. LRRK2 inhibitors show promise for therapy.

View Article
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.